Search

Your search keyword '"Leukemia -- Drug therapy"' showing total 966 results
Start Over Descriptor "Leukemia -- Drug therapy"
966 results on '"Leukemia -- Drug therapy"'

1. Research from Chongqing Academy of Chinese Materia Medica Has Provided New Study Findings on Leukemia (Fabrication of docetaxel-loaded hyaluronic acid coated zeolitic imidazolate framework-8 as an effective treatment for leukaemia cancer cells ...)

Subjects
Drug therapy, Reports, Cancer treatment -- Reports, Physical fitness -- Reports, Cancer research -- Reports, Leukemia -- Drug therapy, Hyaluronic acid -- Reports, Oncology, Experimental -- Reports, Cancer -- Care and treatment -- Research
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on leukemia. According to news reporting originating from [...]

Published
2024

3. Data on Thyroid Cancer Described by Researchers at Shanghai Jiao Tong University (Article Repurposing Homoharringtonine for Thyroid Cancer Treatment Timp1/fak/pi3k/akt)

Subjects
Drug therapy, Thyroid cancer -- Drug therapy, Physical fitness, Cancer research, Leukemia -- Drug therapy, Oncology, Experimental, Cancer -- Research
Abstract

2024 AUG 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Thyroid Cancer have been presented. According to [...]

Published
2024

4. Researchers from Institute for Cancer Research and Treatment (IRCCS) San Raffaele Scientific Institute Discuss Research in Tyrosine Kinase Inhibitors (Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, ...)

Subjects
Drug therapy, Cancer treatment, Physical fitness, Midostaurin, Cancer research, Tyrosine, Hematopoietic stem cells, Sorafenib, Hematopoietic stem cell transplantation, Leukemia -- Drug therapy, Phenols (Class of compounds), Oncology, Experimental, Phenols, Hematopoietic stem cells -- Transplantation, Cancer -- Care and treatment -- Research
Abstract

2024 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on tyrosine kinase inhibitors have been published. According to [...]

Published
2024

5. Data on Leukemia Discussed by Researchers at Fujian Medical University Union Hospital [Cd(II)-based complex loaded with drug doxorubicin hydrogels against leukemia and reinforcement learning]

Subjects
Drug therapy, Reports, Physical fitness -- Reports, Cancer research -- Reports, Leukemia -- Drug therapy, Antineoplastic agents -- Reports, Oncology, Experimental -- Reports, Cancer -- Research, Antimitotic agents -- Reports
Abstract

2024 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on leukemia are discussed in a new report. According to [...]

Published
2024

6. CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy Evolution - ResearchAndMarkets.com

Subjects
Leukemia -- Drug therapy, Chemotherapy -- Health aspects -- Forecasts and trends, Cancer -- Chemotherapy, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025' report has been added to ResearchAndMarkets.com's offering. CD70 targeting therapies are rapidly gaining recognition as a promising [...]

Published
2025

7. CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy Evolution

Subjects
Leukemia -- Drug therapy, Cancer -- Care and treatment, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-January 31, 2025-: CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy [...]

Published
2025

10. New blood test makes cancer treatments safer, more effective: researchers

Subjects
Blood -- Medical examination, Oncology, Experimental, Leukemia -- Drug therapy, Cancer -- Care and treatment -- Research, Business, general, General interest, News, opinion and commentary
Abstract

SYDNEY, December 17, 2024 (Xinhua via COMTEX) -- Australian researchers have developed a new blood test they say could make cancer treatments safer and more effective. In a new study, [...]

Published
2024

11. Tampa General Hospital Announces Launch of Outpatient Cellular-Immunotherapy Transplant Unit at the TGH Cancer Institute

Subjects
Tampa General Hospital, Patients -- Care and treatment, T cells, Leukemia -- Drug therapy, Bone marrow -- Transplantation, Non-Hodgkin's lymphomas -- Drug therapy, Immunotherapy, Medical colleges
Abstract

The New Program Enables Patients with Aggressive Cancers to Receive Cell Therapy Treatment Under Outpatient Care TAMPA, Fla., Dec. 12, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4324051-1&h=998848683&u=https%3A%2F%2Fwww.tgh.org%2F&a=Tampa+General+Hospital(TGH) today announced the opening of a [...]

Published
2024

12. Sunderland girl, 8, dances again after cancer treatment left her unable to use legs; Allana Beeby, 8, could not use her legs after treatment for her leukaemia, but months on she has rebuilt her strength and is back dancing

Subjects
Dancing -- Usage, Leukemia -- Drug therapy, Cancer -- Care and treatment, General interest, News, opinion and commentary
Abstract

Byline: By, Sam Volpe When cancer treatment meant Sunderland tot Allana Beeby lost the use of her legs, she was determined not to let the illness stop her from dancing. [...]

Published
2024

13. Research on Leukemia Discussed by Researchers at Beni-Suef University (Two chromatographic methods for determination of cytarabine and dexamethazone; two co-administered drugs for the treatment of leukemia: green analytical perspective)

Subjects
Drug therapy, Analysis, Reports, Methods, Physical fitness -- Methods -- Analysis -- Reports, Drugs -- Methods -- Reports -- Analysis, Cancer research -- Reports -- Analysis -- Methods, Chromatography -- Analysis -- Reports -- Methods, Leukemia -- Drug therapy, Oncology, Experimental -- Reports -- Analysis -- Methods, Cancer -- Research
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on leukemia are discussed in a new report. According to [...]

Published
2024

14. Reports from Suleyman Demirel University Highlight Recent Research in Drugs and Therapies (Determination of drug-related problems in the hematology service: a prospective interventional study)

Subjects
Drug therapy, Diagnosis, Complications and side effects, Risk factors, Hospital patients -- Drug therapy, Pharmaceutical research, Adverse drug reactions -- Risk factors -- Diagnosis, Leukemia -- Drug therapy, Antineoplastic agents -- Complications and side effects, Drugs -- Adverse and side effects, Antimitotic agents -- Complications and side effects
Abstract

2024 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on drugs and therapies is now available. According to [...]

Published
2024

15. Reports from University of Alexandria Highlight Recent Findings in Leukemia (Enhanced Therapeutic Efficacy of Asparaginase and Chloroquine Co-loaded Zif-8 Nanoparticles for Overcoming L-asparaginase Resistance In Leukemia Treatment)

Subjects
Drug therapy, Health aspects, Asparaginase -- Health aspects, Cancer treatment -- Health aspects, Nanoparticles -- Health aspects, Physical fitness -- Health aspects, Leukemia -- Drug therapy, Cancer -- Care and treatment
Abstract

2024 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Leukemia. According to news reporting [...]

Published
2024

16. New Leukemia Findings from Beckman Research Institute Described (Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery)

Subjects
Drug therapy, Reports, Epigenetic inheritance -- Reports, Physical fitness -- Reports, Cancer research -- Reports, Leukemia -- Drug therapy, Drug discovery -- Reports, Oncology, Experimental -- Reports, Cancer -- Research
Abstract

2024 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on leukemia have been published. According to news reporting [...]

Published
2024

17. Tampa General Hospital Announces Launch of Outpatient Cellular-Immunotherapy Transplant Unit at the TGH Cancer Institute

Subjects
Tampa General Hospital, Drug therapy, Non-Hodgkin lymphomas -- Drug therapy, Bone marrow transplantation, Immunotherapy, Leukemia -- Drug therapy, T cells, Bone marrow -- Transplantation, Non-Hodgkin's lymphomas -- Drug therapy
Abstract

2024 DEC 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Tampa General Hospital (TGH) announced the opening of a new outpatient Cellular-Immunotherapy Transplant Unit (CTU) [...]

Published
2024

18. FDA APPROVES TARGETED THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Subjects
United States. Food and Drug Administration, Oncology, Experimental, Leukemia -- Drug therapy, Stem cells -- Transplantation, Drug approval, Cancer -- Research, News, opinion and commentary
Abstract

RYE BROOK, N.Y. -- The following information was released by the Leukemia & Lymphoma Society: LLS was an early funder of research that identified the CD38 protein as a target [...]

Published
2024

19. KFSHRC Pioneers Cancer Treatment with Breakthrough Therapies and Exceptional Outcomes

Subjects
T cells -- Health aspects, Leukemia -- Drug therapy, Cancer -- Care and treatment, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- RIYADH, Saudi Arabia, Oct. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is revolutionizing cancer treatment in the region with [...]

Published
2024

20. Studies from Shaanxi University of Science and Technology Add New Findings in the Area of Hematology (Computational Studies of Novel Aniline Pyrimidine Wdr5-mll1 Inhibitors: Qsar, Molecular Docking, and Molecular Dynamics Simulation)

Subjects
Drug therapy, Aniline, Molecular dynamics, Pyrimidines, Leukemia -- Drug therapy
Abstract

2024 OCT 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Hematology are presented in a new report. According to news [...]

Published
2024

21. Researchers at Daiichi Sankyo Co. Ltd. Report New Data on Adult T-Cell Leukemia-Lymphoma (Bayesian Sparse Regression for Exposure-response Analyses of Efficacy and Safety Endpoints To Justify the Clinical Dose of Valemetostat for Adult T-cell ...)

Subjects
Daiichi Sankyo Company Ltd. -- Reports, Drug therapy, Reports, Non-Hodgkin lymphomas -- Drug therapy, Cancer research -- Reports, Biochemistry -- Reports, Leukemia -- Drug therapy, Pharmaceutical industry -- Reports, T cells -- Reports, Oncology, Experimental -- Reports, Non-Hodgkin's lymphomas -- Drug therapy, Cancer -- Research
Abstract

2024 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- New research on Oncology - Adult T-Cell Leukemia-Lymphoma is the subject of a report. According [...]

Published
2024

22. GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

Subjects
Biological products industry, Leukemia -- Drug therapy, Killer cells, Clinical trials, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO: GT Biopharma, Inc. has issued the following news release: GT Biopharma, Inc. (the 'Company') (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on [...]

Published
2024

23. FDA APPROVES TARGETED IMMUNOTHERAPY FOR AGGRESSIVE FORMS OF FOLLICULAR LYMPHOMA

Subjects
United States. Food and Drug Administration, Leukemia -- Drug therapy, Non-Hodgkin's lymphomas -- Drug therapy, Immunotherapy, Drug approval, News, opinion and commentary
Abstract

RYE BROOK, N.Y. -- The following information was released by the Leukemia & Lymphoma Society: Epcoritamab works by engaging the immune system to kill cancer cells Rye Brook, N.Y., June [...]

Published
2024

25. Chronic Myelomonocytic Leukaemia Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

Subjects
Novartis Pharma AG -- Product development, Incyte Corp. -- Product development, Business -- Research, Leukemia -- Drug therapy, Biotechnology industry -- Product development, Drug approval -- Reports, Clinical trials -- Reports, Pharmaceutical industry -- Product development, Business, Business, international
Abstract

M2 PRESSWIRE-June 24, 2024-: Chronic Myelomonocytic Leukaemia Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:21062024 DelveInsight's, 'Chronic Myelomonocytic Leukaemia Pipeline Insight 2024' [...]

Published
2024

26. GLOBAL PARTNERSHIP TO FUND GROUNDBREAKING RESEARCH IN TREATMENT OF MULTIPLE MYELOMA

Subjects
Societies, T cells, International cooperation, Leukemia -- Drug therapy, Cancer -- Care and treatment, Associations, institutions, etc., News, opinion and commentary, The Leukemia & Lymphoma Society
Abstract

WHITE PLAINS, NY -- The following information was released by the Leukemia & Lymphoma Society: Groundbreaking research aimed at translating novel chimeric antigen receptor (CAR) T-cell therapies into improved treatment [...]

Published
2024

27. Phase 2 Findings Show Wugen's Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress

Subjects
T cells, Leukemia -- Drug therapy, Killer cells, Nelarabine, Banking, finance and accounting industries, Business
Abstract

-- Researchers Shared Findings Including a Clinically Manageable Safety Profile and Anti-leukemic Activity with WU-CART-007 in Patients with R/R T-ALL/LBL and Previously Treated with Existing Therapies -- U.S. Biotech Wugen [...]

Published
2024

29. Reports Outline Drug Resistance Research from Chiang Mai University [Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional ...]

Subjects
Drug therapy, Prevention, Physiological aspects, Usage, Health aspects, Transport proteins -- Physiological aspects -- Health aspects, Polyphenols -- Physiological aspects -- Health aspects -- Usage, Drug resistance -- Prevention -- Physiological aspects, Leukemia -- Drug therapy, Carrier proteins -- Physiological aspects -- Health aspects
Abstract

2023 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in drug resistance. According to news originating from [...]

Published
2023

30. Cancer treatment breakthrough: India's homegrown CAR-T cell therapy, a form of immunotherapy, gets market authorisation

Subjects
T cells, Leukemia -- Drug therapy, Immunotherapy, B cells, Cancer -- Care and treatment, Company business management, Environmental issues, Regional focus/area studies
Abstract

India, Oct. 13 -- It is a major breakthrough as the therapy is not available in India outside of clinical trials For treating relapsed-refractory B-cell lymphoma and leukemia, Mumbai-based Immunoadoptive [...]

Published
2023

31. Study Findings from Nanjing Forestry University Advance Knowledge in Leukemia (Synthesis and anti-leukemia activity of phorbol 13,20-diesters and phorbol 12,13,20-triesters)

Subjects
Production processes, Drug therapy, Chemical properties, Research, Health aspects, Phorbol esters -- Production processes -- Health aspects -- Chemical properties, Pharmaceutical research, Leukemia -- Drug therapy, Antineoplastic agents -- Research, Antimitotic agents -- Research
Abstract

2023 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on leukemia. According to news reporting from Nanjing, [...]

Published
2023

32. FDA APPROVES A NEW IMMUNE-BASED TREATMENT OPTION FOR PEOPLE WITH MANTLE CELL LYMPHOMA

Subjects
United States. Food and Drug Administration, T cells, Leukemia -- Drug therapy, Non-Hodgkin's lymphomas -- Drug therapy, Immunotherapy, News, opinion and commentary
Abstract

RYE BROOK, N.Y. -- The following information was released by the Leukemia & Lymphoma Society: The FDA continues to expand availability of breakthrough CAR T-cell immunotherapy to benefit more blood [...]

Published
2024

33. Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy Evolution

Subjects
Leukemia -- Drug therapy, Cancer -- Care and treatment, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024' report has been added to ResearchAndMarkets.com's offering. Global [...]

Published
2024

34. PLK Targeted Therapies Market & Clinical Trials 2024: Onvansertib Leading the Way in PLK1 Inhibition, Pioneering Breakthroughs in Small Cell Lung Cancer and Chronic Myelomonocytic Leukemia Treatment

Subjects
Respiratory agents -- Health aspects -- Forecasts and trends, Leukemia -- Drug therapy, Chemotherapy -- Health aspects -- Forecasts and trends, Lung cancer -- Drug therapy, Cancer -- Chemotherapy, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024' report has been added to ResearchAndMarkets.com's offering. Global [...]

Published
2024

35. PLK Targeted Therapies Market & Clinical Trials 2024: Onvansertib Leading the Way in PLK1 Inhibition, Pioneering Breakthroughs in Small Cell Lung Cancer and Chronic Myelomonocytic Leukemia Treatment - ResearchAndMarkets.com

Subjects
Respiratory agents -- Health aspects -- Forecasts and trends, Leukemia -- Drug therapy, Immunotherapy -- Forecasts and trends -- Health aspects, Chemotherapy -- Health aspects -- Forecasts and trends, Lung cancer -- Drug therapy, Cancer -- Chemotherapy, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024' report has been added to ResearchAndMarkets.com's offering. Global PLK Targeted Therapies Market Opportunity & Clinical Trials [...]

Published
2024

36. Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy Evolution - ResearchAndMarkets.com

Subjects
Leukemia -- Drug therapy, Cancer -- Care and treatment, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024' report has been added to ResearchAndMarkets.com's offering. Global CD70 Targeting Therapies Market Opportunity & Clinical Trials [...]

Published
2024

37. Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 Therapy Evolution

Subjects
Leukemia -- Drug therapy, Cancer -- Care and treatment, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-April 29, 2024-: Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024: Cusatuzumab Emerges as Leading Phase II Candidate for Leukemia Treatment, Paving the Way for CD70 [...]

Published
2024

38. CHILDREN AND YOUNG ADULTS TO BENEFIT AFTER NICE RECOMMENDS PERSONALISED IMMUNOTHERAPY TO TREAT BLOOD CANCER BE MADE ROUTINELY AVAILABLE ON THE NHS

Subjects
Leukemia -- Drug therapy, Cancer -- Care and treatment, Multiple myeloma -- Drug therapy, News, opinion and commentary
Abstract

LONDON -- The following information was released by the National Institute for Health and Clinical Excellence (UK): Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia 11 April [...]

Published
2024

39. Shorla Oncology announces FDA acceptance of drug application to treat leukemia

Subjects
Antineoplastic agents, Leukemia -- Drug therapy, Drugs -- Prescribing, Oral medication, Antimitotic agents, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: Shorla Oncology ('Shorla'), a U.S.-Ireland specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for SH-201, [...]

Published
2024

40. Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

Subjects
United States. Food and Drug Administration, Leukemia -- Drug therapy, Drugs -- Prescribing, Chemotherapy, Cancer -- Chemotherapy, Oral medication, Nelarabine, News, opinion and commentary
Abstract

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 8, 2024-- Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New [...]

Published
2024

41. Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

Subjects
United States. Food and Drug Administration, Leukemia -- Drug therapy, Drugs -- Prescribing, Chemotherapy, Cancer -- Chemotherapy, Oral medication, Nelarabine, Business, Business, international
Abstract

Second FDA Acceptance for an NDA Filing by Shorla Oncology Announced in 2024 New Oral Liquid Drug from the U.S.-Ireland Pharmaceutical Company Slows or Stops the Growth of Certain Types [...]

Published
2024

42. FDA'S ODAC ENDORSES NEW INDICATIONS FOR 2 CAR-T THERAPIES FOR MYELOMA

Subjects
T cells, Leukemia -- Drug therapy, Cancer -- Care and treatment, News, opinion and commentary
Abstract

RYE BROOK, N.Y. -- The following information was released by the Leukemia & Lymphoma Society: Today's vote by the FDA's Oncologic Drugs Advisory Committe (ODAC), a group of independent cancer [...]

Published
2024

43. Data from Dr. B.R.A. Institute Rotary Cancer Hospital Provide New Insights into Solid Cancer (Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting)

Subjects
Drug therapy, Physiological aspects, Palonosetron -- Physiological aspects, Chemotherapy -- Physiological aspects, Leukemia -- Drug therapy, Nausea -- Drug therapy, Aprepitant -- Physiological aspects, Cancer -- Chemotherapy
Abstract

2024 JUN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- New research on solid cancer is the subject of a new report. According to news [...]

Published
2024

44. New NHS drug to help patients suffering blood cancers such as leukaemia and lymphoma; NHS chief said 'This rollout is a real breakthrough for patients'

Subjects
Cancer patients -- Drug therapy, Leukemia -- Drug therapy, Bone marrow -- Transplantation, Stem cells -- Transplantation, Lymphomas -- Drug therapy, Multiple myeloma -- Drug therapy, Donation of organs, tissues, etc., General interest, News, opinion and commentary
Abstract

Byline: By, Ben Hurst Cancer patients can get a new wonder drug on the NHS to help them battle a rare disease which attacks the body's own organs following a [...]

Published
2024

46. Advances in blood cancer treatments

Subjects
Medical research, Medicine, Experimental, Leukemia -- Drug therapy, Non-Hodgkin's lymphomas -- Drug therapy, Cancer -- Care and treatment
Abstract

Blood cancers often affect people younger than the average person who develops cancer, and Australian and New Zealand haematologists have been pioneers in trialling new treatments-this year marking the 50th [...]

Published
2023

50. New Leukemia Study Findings Have Been Reported from University of Washington (Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure)

Subjects
Drug therapy, Usage, Innovations, Dosage and administration, Health aspects, Venetoclax -- Dosage and administration -- Innovations, Nanotechnology -- Usage -- Health aspects, Combination drug therapy -- Usage -- Innovations, Zanubrutinib -- Dosage and administration -- Innovations, Leukemia -- Drug therapy, Drug therapy, Combination -- Usage -- Innovations
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on leukemia are presented in a new report. According to [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results